OR WAIT 15 SECS
November 19, 2020
Gut bacteria may be partially responsible for metabolic changes that lead to weight gain following chemotherapy treatment, according to a recent study.
November 17, 2020
The phase 1b clinical trial combined olaparib with capivasertib to treat patients with germline BRCA1/2 mutations and BRCA1/2 wild-type cancers.
The FDA approved Merck's blockbuster cancer drug, pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer.
November 16, 2020
How community pharmacists can advance care as patients come home.
November 10, 2020
Pharmacists-in-training have a valuable impact on cancer care, according to authors of a recent journal article.
Many opportunities exist for pharmacists within the multidisciplinary care team to ensure the delivery of optimal cancer care.
October 13, 2020
The rate of prescribing opioids among both oncologists and non-oncologists has dropped significantly in the past few years.
October 12, 2020
Pharmacists are uniquely qualified to ensure patients receive sufficient pain relief.
October 05, 2020
Nivolumab plus ipilimumab decreased tumor growth in patients with untreated unresectable malignant pleural mesothelioma.
New policy recommendations aim to increase the uptake of biomarker testing and advance health insurance coverage for precision medicine in cancer care.
October 01, 2020
Investigators reported that, compared with chemotherapy, atezolizumab monotherapy was superior in overall survival and progression-free survival in patients with NSCLC.
September 11, 2020
The FDA issued a safety alert about efficacy and potential safety concerns with a combination therapy being studied for the treatment of breast cancer.
September 10, 2020
Oncology pharmacists have implemented new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens during the pandemic.
September 03, 2020
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to a major new study.
Oral azacitidine (Onureg; Celgene) is approved for patients in first remission with acute myeloid leukeimia.
August 19, 2020
Oncology medical and infusion services have declined since the start of COVID-19.
August 13, 2020
Results from the study showed antitumor activity and safety to be similar to olaparib and durvalumab monotherapy study findings.
August 12, 2020
Pharmacists should counsel patients on how taking steps now can prevent certain cancers later.
August 07, 2020
The advent of generic and biosimilar medicines for novel treatments has helped bridge the gap in the delivery of cancer care between the United States and India, according to the study.
August 06, 2020
ESMO released changes to its recommendations on how to manage patients with cancer during the COVID-19 pandemic.
